In November 2023, the FDA approved the first therapeutic for a rare blood disorder called TTP. The research at the foundation of this treatment started in the lab of U-M physician scientist David Ginsburg. See the Innovation Partnerships 2024 Impact Report for more information on how a basic science question ultimately led to this approved treatment.
We are excited to share Innovation Partnerships’ Fiscal Year 2024 Impact Report! This year’s report highlights inspiring success stories from across the University of Michigan. Discover incredible startups and projects and learn about impactful researchers, including the 2024 Distinguished University Innovator of the Year, Kevin R. Ward, MD. Plus, celebrate another record-breaking year for research commercialization. Get the full story and read the report here: https://myumi.ch/5yXXA